• Info
  • Insider Ownership

Insider Trading & Ownership of Andrew Sinclair

Location
Redwood City, CA
Summary
The estimated net worth of Andrew Sinclair is at least $810,840 dollars as of 13 Jun 2025. Andrew Sinclair is the Director of SOLENO THERAPEUTICS INC and owns shares of SOLENO THERAPEUTICS INC (SLNO) stock worth about $800K. Andrew Sinclair is the Director of Adicet Bio, Inc. and owns shares of Adicet Bio, Inc. (ACET) stock worth about $10.8K.
Signature
/s/ Nick Harvey, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Andrew Sinclair and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • Andrew Sinclair has 4 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $810,840.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: SOLENO THERAPEUTICS INC ($800,043).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Andrew Sinclair

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SLNO SOLENO THERAPEUTICS INC Director $800,043 05 Jun 2025
ACET Adicet Bio, Inc. Director $10,797 11 Jun 2025
SRRA Sierra Oncology, Inc. Director 01 Jul 2022
VRNA Verona Pharma plc Director 09 Aug 2021

Insider Transactions Reported by Andrew Sinclair:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored